These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6985188)

  • 21. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
    Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers.
    Schaefer PL; Marks RS; Mahoney MR; Sloan JA; Bauman MD; Tazelaar HD; Kugler JW; Mailliard JA; Ebbert LP; Wiesenfeld M
    Am J Clin Oncol; 2003 Jun; 26(3):236-40. PubMed ID: 12796591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
    Murren J; Modiano M; Clairmont C; Lambert P; Savaraj N; Doyle T; Sznol M
    Clin Cancer Res; 2003 Sep; 9(11):4092-100. PubMed ID: 14519631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
    Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study on the efficacy of combination chemoendocrine therapy consisting of cyclophosphamide, adriamycin, UFT, and tamoxifen for advanced or recurrent breast cancer].
    Yamaguchi S; Fukuda M; Ota T; Nakayama Y; Ogata H; Shimizu K; Nishikawa T; Adachi Y; Fukuma E
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1145-52. PubMed ID: 10431580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer.
    Chang AY; Garrow GC
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):66-70; discussion 70-1. PubMed ID: 7740336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phase II study of a new fluorinated pyrimidine, ethyl (+/-)-t-6-butoxy-5-fluoro-2, 4-dioxohexahydropyrimidine-r-5-carboxylate (TAC-278)].
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1821-6. PubMed ID: 7184376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
    Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L
    Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical evaluation of intra-arterial infusion chemotherapy for advanced or recurrent pelvic tumors with or without radiotherapy].
    Kaneyasu Y; Okawa MK; Kokubo N; Takemoto M; Karasawa K; Fukuhara N; Toda J; Okawa T
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1486-93. PubMed ID: 8854787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of scleroderma.
    Meyers D
    Med J Aust; 1977 Jun; 1(24):887. PubMed ID: 301981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antifibrinolytic therapy of subarachnoid hemorrhage. Permeation of oral paraaminomethylbenzoic acid in the cerebrospinal fluid].
    Hindersin P; Heidrich R; Endler S
    Psychiatr Neurol Med Psychol (Leipz); 1980 Apr; 32(4):214-9. PubMed ID: 6968077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intrathecal administration of antifibrinolytics in primary subarachnoid hemorrhage during the acute period].
    Leska P; Krupka J; Nakládal J; Volcík P
    Cesk Neurol Neurochir; 1987 Jan; 50(1):17-23. PubMed ID: 3492295
    [No Abstract]   [Full Text] [Related]  

  • 34. [Divascan and Pamba in the prevention of alveolitis following tooth extraction].
    Schroeder H
    Zahn Mund Kieferheilkd Zentralbl; 1986; 74(3):259-64. PubMed ID: 2941940
    [No Abstract]   [Full Text] [Related]  

  • 35. New approaches in administration of anticancer drugs.
    Rall DP
    Cancer Res; 1969 Dec; 29(12):2471-4. PubMed ID: 5369694
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic activity of aminaphthone in purpuric disorders].
    Chimenti S; Faina P
    Clin Ter; 1978 Mar; 84(5):501-8. PubMed ID: 306333
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cytostatic chemotherapy in the treatment of malignant tumors].
    Langhammer H; Klemm J; Pabst HW
    Arztl Forsch; 1966 Aug; 20(8):393-403. PubMed ID: 6014703
    [No Abstract]   [Full Text] [Related]  

  • 38. [On intralymphatic administration of antineoplastic agents].
    Porzio R; Giannattasio G; Carbone R; Di Stefano G
    Minerva Med; 1970 May; 61(43):2405-16. PubMed ID: 5425727
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical phase II trial of a new antineoplastic drug--glyciphosphoramide].
    Sun Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Aug; 6(4):273-6. PubMed ID: 6241067
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of cyclosporine-associated nephrotoxicity by K-MAP.
    Teraoka S; Sanaka T; Sato H; Fuchinoue S; Honda H; Kawai T; Nakajima I; Tojinbara T; Fujita S; Funakoshi Y
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):179-82. PubMed ID: 3279608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.